期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
肿瘤大数据在抗肿瘤药物应用中的研究进展 被引量:6
1
作者 周海辉 张海霞 +1 位作者 严婷婷 葛卫红 《现代药物与临床》 CAS 2018年第11期3079-3082,共4页
世界范围内肿瘤大数据已经取得了长足的进步,总结了肿瘤大数据在抗肿瘤药物应用中的研究进展,包括肿瘤流行病学、肿瘤早期诊断、新靶点和新适应症的发现、不良反应的信号发掘、患者预后模型的构建,以及肿瘤大数据存在的不足,如数据的采... 世界范围内肿瘤大数据已经取得了长足的进步,总结了肿瘤大数据在抗肿瘤药物应用中的研究进展,包括肿瘤流行病学、肿瘤早期诊断、新靶点和新适应症的发现、不良反应的信号发掘、患者预后模型的构建,以及肿瘤大数据存在的不足,如数据的采集、可信度、保存、安全性等。 展开更多
关键词 肿瘤大数据 肿瘤药物 精准医学
原文传递
医疗大数据平台建设机遇、挑战及其发展 被引量:22
2
作者 郭强 王丛 衡反修 《医学信息学杂志》 CAS 2021年第1期2-8,共7页
分析医疗大数据平台建设面临的机遇和挑战,以肿瘤大数据平台为例阐述医疗大数据平台发展建设情况,包括建设规划、关键技术领域研究、建设实践等,为医疗卫生行业数字化、智能化转型提供支撑。
关键词 医疗大数据 肿瘤大数据 数据治理
下载PDF
Optimizing medication strategies for liver cancer:unraveling the mechanisms of key drug combinations in the comprehensive guide to effective tumor prescriptions
3
作者 Xiao Zhang Ye Zhong +1 位作者 Yongsheng Hu Bolong Wang 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2024年第7期647-658,共12页
This study delved into the formulaic patterns of liver cancer treatment outlined in“The Complete Book of Good Tumor Prescriptions”and explored the action mechanisms of core traditional Chinese medicine(TCM)combinati... This study delved into the formulaic patterns of liver cancer treatment outlined in“The Complete Book of Good Tumor Prescriptions”and explored the action mechanisms of core traditional Chinese medicine(TCM)combinations.Initially,liver cancer treatment formulas were extracted from the aforementioned book,and Excel 2017 was employed for calculating the frequency,properties,and meridians associated with the TCMs.IBM SPSS Modeler 18.0 was utilized for the analysis of TCM association rules,and Cytoscape 3.7.2 was employed for the visualization of these rules.Subsequently,network pharmacology was utilized to analyze the action mechanisms of core TCM combinations,leveraging TCMSP,TCMID,Genecards,DAVID,and other databases.The results revealed the inclusion of 131 prescriptions encompassing 303 TCMs.The core TCMs predominantly comprised those invigorating blood circulation and removing blood stasis,clearing heat,and tonifying deficiencies.The flavor of the TCMs was chiefly bitter or pungent,with a prevailing cold property entering the liver and spleen meridians.Association analysis indicated that the support of Angelicae sinensis radix-Trionycis carapax was the highest.Network pharmacology predictions indicated that Angelicae sinensis radix-Trionycis carapax possessed 20 target genes associated with anti-liver cancer properties,including IL-6,MAPK3,and SRC.Gene survival analysis demonstrated high expression of MAPK3 and SRC in liver cancer patients,correlating with a poor prognosis.KEGG analysis identified major anti-liver cancer pathways for Angelicae sinensis radix-Trionycis carapax,encompassing the cancer pathway,TNF signaling pathway,and prolactin signaling pathway.In summary,this study elucidated that TCMs for liver cancer treatment primarily consisted of invigorating blood circulation and removing blood stasis,antipyretic,and tonifying medicines.The core TCM pair,Angelicae sinensis radix-Trionycis carapax,appeared pivotal in this context.The underlying mechanism might involve the modulation of key genes,such as MAPK3 and SRC,and the regulation of pathways,including the cancer pathway,TNF signaling pathway,and prolactin signaling pathway. 展开更多
关键词 The Complete Book of Good Tumor Prescriptions Liver cancer Angelicae sinensis radix Trionycis carapax Data mining Network pharmacology
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部